Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

At AAD 2025, five-year data for BIMZELX® (bimekizumab-bkzx) demonstrated sustained skin clearance and long-term efficacy in moderate-to-severe plaque psoriasis

UCB, a global biopharmaceutical company, announced further long-term data from the Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe plaque psoriasis (PSO). Dual inhibition...

MedaSystems secures additional seed financing to advance its AI-driven workflow platform, expanding access and supporting investigator-initiated studies

MedaSystems, the leading SaaS platform for Expanded Access (EA) and Investigator-Initiated Studies (IIS), announced additional funding from existing investors, Debiopharm Innovation Fund, Nina Capital, and Young Sohn, a co-founder of Veeva...

Newly-formed Archerfish Precision Diagnostics Pte Ltd ushers in a new era in advanced diagnostics

In a significant development for the clinical diagnostics landscape in Singapore, Angsana Molecular & Diagnostics Laboratory (Angsana) and Pathnova Laboratories (Pathnova) have announced their merger to form Archerfish Precision Diagnostics...

Shorla Oncology Announces the Launch of Dedicated Sales Force and Market Access Teams as Part of Expansion of Its U.S. Commercial Footprint

Shorla Oncology a U.S.-Ireland specialty pharmaceutical company, announced the launch of a dedicated sales force and market access teams and the commercial availability of IMKELDI, the first oral liquid form of imatinib to treat certain forms of...

"Latigo Biotherapeutics has been granted FDA Fast Track Designation for LTG-001, a potential best-in-class Nav1.8 inhibitor for the non-opioid treatment of acute pain

Latigo Biotherapeutics ("Latigo") announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to LTG-001, the company's oral, investigational selective Nav1.8 inhibitor for the treatment of acute pain. LTG-001...

Dr. Scott Grady Makes Thyroid RFA More Accessible in Oregon

Dr. Scott Grady, an endocrinologist at Portland Diabetes & Endocrinology Center (PDEC), is making Thyroid Radiofrequency Ablation (RFA) more accessible to Oregon patients seeking a non-surgical alternative for benign thyroid nodules. Since 2022,...

TOOsonix Partners with MikronMed to Introduce Innovative Dermatological Therapy in the Nordic Region

TOOsonix A/S, a leader in high-intensity focused ultrasound technology for dermatology, has partnered with MikronMed AB, a top distributor of medical equipment in the Nordic region. The collaboration will bring TOOsonix innovative MDR CE marked...

Cellino Launches the U.S.’s First Nebula-Powered iPSC Foundry for Scalable Autologous Biomanufacturing

Cellino announced its collaboration with Mass General Brigham’s Gene and Cell Therapy Institute (GCTI) to launch the world’s first hospital-based autologous induced pluripotent stem cell (iPSC) Foundry. Powered by Cellino’s AI-driven Nebula...

Vector Laboratories Appoints Ashley Scholz as Vice President of Marketing

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced the appointment of Ashley Scholz as Vice...

LabConnect and Australian Clinical Labs' Specialised Trials Announce a Strategic Partnership in the Australia and Asia Pacific Region

LabConnect and Australian Clinical Labs' (ACL) Specialised Trials have forged a strategic partnership to expand support of clinical trials in Australia and the Asia-Pacific region. This exclusive, multi-year agreement solidifies the partnership,...

Regemat 3D to Distribute VitroInk® Bioinks in Europe: A Strategic Move for Advanced Bioprinting Solutions

TheWell Bioscience, a leading biotech company specializing in xeno-free biofunctional hydrogels and bioinks, is pleased to announce the non-exclusive distribution of its products through REGEMAT 3D, a leading biotech company specializing in the...

A convenient and cost-effective way to treat sickle cell disease may be offered by Vascarta's patented transdermal drug candidate

studies in which humanized sickle cell mice topically treated with Vascarta's transdermal curcumin gel formulation ("VAS-101") experienced reduced pain and inflammation along with improved red blood cell stability and functionality. Based in part...

MAYPHARM CO., LTD. launches SKINCOLLA, the world's first recombinant human collagen filler for superior skin rejuvenation

MAYPHARM CO., LTD. proudly introduces SKINCOLLA, the world's first recombinant human collagen filler, marking a significant breakthrough in skin rejuvenation technology. Utilizing Demulcent™ Type I recombinant collagen, SKINCOLLA offers natural...

Fosun Pharma deeply embraces AI, with its self-developed PharmAID Decision Intelligence Platform boosting efficient innovation

Nowadays, artificial intelligence (AI) technology is profoundly reshaping the landscape of the pharmaceutical and healthcare industry. As a global innovation-driven pharmaceutical and healthcare group, Fosun Pharma places great emphasis on the...

"Grindeks, the leading pharmaceutical company in the Baltics, expands to new export markets worldwide

The leading pharmaceutical company in the Baltics, Grindeks, continues to strengthen its global presence by entering new export markets. This year, for the first time, Grindeks products will be delivered to Panama. The company's export markets...

Fresenius Kabi Launches Calcitonin Salmon Injection, USP Synthetic

Fresenius Kabi, an operating company of Fresenius, announced today it has introduced Calcitonin Salmon Injection, USP Synthetic, a calcium regulator, for the treatment of symptomatic Paget’s disease of the bone and hypercalcemia. The drug is also...

Marius Pharmaceuticals Expands Men's Health Solutions by Announcing the Availability of KYZATREX® (testosterone undecanoate) CIII Capsules Through Thrive

Marius Pharmaceuticals is pleased to announce that Thrive, a leading provider of personalized healthcare solutions and a trusted partner of O2 Fitness, now offers KYZATREX® (testosterone undecanoate) CIII capsules to its patients nationwide....

Centinel Spine's Match-the-Disc™ prodisc® Cervical Total Disc Replacement System has completed over 10,000 procedures in the U.S

Centinel Spine®, LLC the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world...

Jabil acquires Pharmaceutics International, Inc

Jabil Inc. a global leader in engineering, manufacturing, and supply chain solutions, announced the successful acquisition of Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO) specializing in...

Zafrens expands its investor syndicate to scale its revolutionary drug discovery platform

Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare,...